One-size fits all? Application of Susceptible-Dose Dependent Breakpoints to Pediatric Patients and Laboratory Reporting.
The Clinical Laboratory Standards Institute antimicrobial and antifungal standards define a susceptible-dose dependent (SDD) category for certain organisms and drugs combinations. Reporting MICs within the SDD category suggests treatment success is likely with increased drug exposure. These breakpoints are based on pharmacokinetic, pharmacodynamic, and clinical outcomes data from adults and not pediatric patients. This commentary aims to discuss the implications of reporting SDD interpretations for pediatric patients and recommends laboratory reporting comments.